Grant support
The Baromedical Research Foundation has been awarded a substantial research grant from Sechrist Industries, Inc., to study hyperbaric oxygen’s radiation sensitization effects. Study design, involving squamous cell carcinomas of the head and neck, has been completed. It involves both Phase I (dose escalation) and Phase III (randomized and double-blinded) components. Participating centers are The Mayo Clinic, Rochester, Minnesota, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, Sentara Norfolk General Hospital, Norfolk, Virginia and Palmetto Health Richland Hospital, Columbia, South Carolina.
Foundation director Dick Clarke notes ‘The best treatment for this form of cancer is not presently known. There is clearly room for long-term survival improvement, with tumor hypoxia a limiting factor in its control and eradication. This important award provides the opportunity to fully investigate the potential of hyperbaric oxygen to impact survival’.
For further information please contact rclarke@baromedicalresearch.org.